Faculty Opinions recommendation of Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study.
2016 ◽
Vol 36
(4)
◽
pp. 418-426
◽
2011 ◽
Vol 33
(12)
◽
pp. 1974-1984
◽
1999 ◽
Vol 29
◽
pp. 125-128
◽
2012 ◽
Vol 53
(3)
◽
pp. 238-244
◽
2012 ◽
Vol 19
(4)
◽
pp. 681-692
◽